OriGene Logo
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
Webinar on Verified Antigen
Verified Antigen Webinar

Browse all lysates


spacer
OriGene in recent publications
Repurposing of Proton Pump Inhibitors as first identified small molecule inhibitors of endo-β-N-acetylglucosaminidase (ENGase) for the treatment of NGLY1 deficiency, a rare genetic disease Bioorg. Med. Chem. Lett. 2017 [ENGASE]

Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica Sci Transl Med 2017 [HSPA5]

Amplification of F-Actin Disassembly and Cellular Repulsion by Growth Factor Signaling Dev. Cell 2017 [STK38L]

Tyr42 phosphorylation of RhoA GTPase promotes tumorigenesis through nuclear factor (NF)-κB Free Radic. Biol. Med. 2017 [VAV2]

View All Citations >>

spacer

74 TrueClone belong to pathway "glycosphingolipid biosynthesis - lacto and neolacto series"

divider

  Page: 1 of 4 
Direct Download
spacer
SKUAccnSymbolDescriptionShipping
SC104850AK021929ST3GAL4 (untagged)-Human cDNA FLJ11867 fis, clone HEMBA1006976, weakly similar to H.sapiens mRNA for Gal-beta(1-3/1-4)GlcNAc alpha-2.3-sialyltransferase2
SC106413NM_032047B3GNT5B3GNT5 (untagged)-Human UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 (B3GNT5)0
SC109759NM_006279ST3GAL3ST3GAL3 (untagged)-Human ST3 beta-galactoside alpha-2,3-sialyltransferase 3 (ST3GAL3), transcript variant 100
SC111083NM_003783B3GALT2B3GALT2 (untagged)-Human UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 (B3GALT2)0
SC115078NM_014256B3GNT3B3GNT3 (untagged)-Human UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3)0
SC115826NM_006876B4GAT1B3GNT1 (untagged)-Human UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1)0
SC116005NM_006577B3GNT2B3GNT2 (untagged)-Human UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 (B3GNT2)0
SC116007NM_006581FUT9FUT9 (untagged)-Human fucosyltransferase 9 (alpha (1,3) fucosyltransferase) (FUT9)0
SC116324NM_006100ST3GAL6ST3GAL6 (untagged)-Human ST3 beta-galactoside alpha-2,3-sialyltransferase 6 (ST3GAL6)0
SC117759NM_003778B4GALT4B4GALT4 (untagged)-Human UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4 (B4GALT4), transcript variant 20
SC117761NM_003780B4GALT2B4GALT2 (untagged)-Human UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 (B4GALT2), transcript variant 20
SC118261NM_003034ST8SIA1ST8SIA1 (untagged)-Human ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 (ST8SIA1)4
SC119201NM_001491GCNT2GCNT2 (untagged)-Human glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group) (GCNT2), transcript variant 20
SC119205NM_001497B4GALT1B4GALT1 (untagged)-Human UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (B4GALT1)0
SC124687NM_174964ST3GAL3ST3GAL3 (untagged)-Human ST3 beta-galactoside alpha-2,3-sialyltransferase 3 (ST3GAL3), transcript variant 20
SC125827NM_030765B3GNT4B3GNT4 (untagged)-Human UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 (B3GNT4)0
SC300016NM_000148FUT1FUT1 (untagged)-Human fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) (FUT1)0
SC300017NM_000149FUT3FUT3 (untagged)-Human fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) (FUT3), transcript variant 10
SC300018NM_000150FUT6FUT6 (untagged)-Human fucosyltransferase 6 (alpha (1,3) fucosyltransferase) (FUT6), transcript variant 10
SC300951NM_001005417B4GALT2B4GALT2 (untagged)-Human UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 (B4GALT2), transcript variant 33

 

pattern
Inc 5000 Healthcare Company